Sai Life Sciences Limited (NSE:SAILIFE)

Sai Life Sciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	-	1,109	911.19	236.57	699.12	1,159
Short-Term Investments	-	469.92	2,811	1,610	1,350	1,000
Cash & Short-Term Investments	1,579	1,579	3,723	1,847	2,049	2,159
Cash Growth	-65.97%	-57.59%	101.59%	-9.88%	-5.11%	12.61%
Accounts Receivable	-	3,736	7,544	5,624	4,618	4,893
Other Receivables	-	-	324.01	276.76	352.2	45.07
Receivables	-	3,736	7,868	5,901	4,971	4,938
Inventory	-	1,510	1,189	874.43	1,395	1,269
Prepaid Expenses	-	-	248.17	212.11	150.76	173.28
Restricted Cash	-	-	1,118	-	-	-
Other Current Assets	-	7,281	899.74	617.5	1,074	913.58
Total Current Assets	-	14,105	15,045	9,451	9,640	9,454
Property, Plant & Equipment	-	20,792	16,018	12,730	11,765	11,527
Long-Term Investments	-	35.1	19.43	18.68	18.68	0.16
Other Intangible Assets	-	61.17	108.56	137.73	114.33	80.5
Long-Term Deferred Tax Assets	-	134.35	141.97	131.33	80.62	57.06
Other Long-Term Assets	-	1,134	266.56	282.85	248.46	523.95
Total Assets	-	36,261	31,600	22,751	21,866	21,642

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	-	2,853	3,225	1,385	2,089	1,992
Accrued Expenses	-	200.36	1,208	869.78	203.54	146.72
Short-Term Debt	-	746.21	1,286	3,743	3,720	4,041
Current Portion of Long-Term Debt	-	-	-	586.13	662.95	500.88
Current Portion of Leases	-	657.07	590.58	417.76	373.49	245.61
Current Income Taxes Payable	-	516.6	79.7	-	33.67	25.67
Other Current Liabilities	-	3,363	935.19	397.62	505.76	194.45
Total Current Liabilities	-	8,337	7,325	7,399	7,589	7,146
Long-Term Debt	-	205.04	-	2,777	2,614	2,977
Long-Term Leases	-	1,276	1,647	1,757	1,958	1,896
Pension & Post-Retirement Benefits	-	-	170.57	142.83	123.12	139.61
Long-Term Deferred Tax Liabilities	-	1,283	1,110	862.66	625.34	625.99
Other Long-Term Liabilities	-	323.18	63.51	60.93	76.11	72.91
Total Liabilities	-	11,425	10,316	13,000	12,986	12,857

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	-	211.78	208.41	176.63	176.23	175.56
Additional Paid-In Capital	-	-	13,732	3,892	3,876	3,856
Retained Earnings	-	-	7,245	5,534	4,696	4,641
Comprehensive Income & Other	-	24,625	97.99	145.18	129.41	109.81
Total Common Equity	24,837	24,837	21,284	9,748	8,877	8,782
Shareholders' Equity	24,837	24,837	21,284	9,751	8,881	8,786
Total Liabilities & Equity	-	36,261	31,600	22,751	21,866	21,642

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	2,885	2,885	3,524	9,281	9,329	9,659
Net Cash (Debt)	-1,306	-1,306	198.71	-7,435	-7,279	-7,500
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-6.14	-6.15	1.01	-40.65	-39.91	-41.30
Filing Date Shares Outstanding	211.81	211.43	208.41	183.92	176.23	175.56
Total Common Shares Outstanding	211.81	211.43	208.41	176.63	176.23	175.56
Working Capital	-	5,769	7,720	2,052	2,051	2,308
Book Value Per Share	117.47	117.47	102.12	55.19	50.37	50.02
Tangible Book Value	24,776	24,776	21,175	9,610	8,763	8,701
Tangible Book Value Per Share	117.18	117.18	101.60	54.41	49.72	49.56
Land	-	-	551.65	188.63	174.98	164.86
Buildings	-	-	3,552	3,055	2,614	2,134
Machinery	-	-	11,385	8,872	7,118	6,724
Construction In Progress	-	-	1,245	1,069	1,510	1,887
Leasehold Improvements	-	-	172.2	169.27	174.29	168.75

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 22, 2026

Data Sources Report a data error